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Summary
 
Previous activation of effector Th2 cells is central to the development of allergic inflammatory
responses. We have observed that priming of allergen-specific Th2 cells in C57BL/6 or B10.A mice with allergen
delivered via the i.p. or s.c. routes results in very different outcomes following subsequent airway exposure to the
same allergen. Systemic allergen immunization (via the i.p. route) resulted in the formation of a lung-resident
population of allergen-specific T cells, and mice developed severe allergic airway inflammation in response to
inhaled allergen. The localization of cells to the lung did not require the presence of antigen at this site, but reflected
a large pool of circulating activated allergen-specific T cells. In contrast, localized immunization (via the s.c. route)
resulted in a small T-cell response restricted to the draining lymph node, and mice were not responsive to inhaled
allergen. These data indicate that prior sensitization to an allergen alone was not sufficient for the induction of
allergic inflammation; rather, responsiveness was largely determined by precursor frequency and tissue localization
of the allergen-specific effector Th2 cells.
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Introduction
 
Allergen induced airway inflammation is a major component
of the pathology and morbidity of atopic asthma. However,
the process by which an individual’s airways become sensi-
tized to an allergen is poorly understood. In mouse models of
airway inflammation, a defined series of events must occur.
The first event involves sensitization against a specific
antigen and the development of responsive Th2 cells. This
sensitizes the host towards the development of allergic airway
inflammation following re-exposure to allergen.
 
1
 
 The current
dogma suggests that only antigen experienced T cells will
express the necessary adhesion molecules required to recircu-
late into those peripheral tissues afflicted by allergies, such as
the lung, skin and intestinal mucosa.
 
2–4
 
 Consequently, only
those effector T cells that have previously encountered the
allergen will be able to generate a rapid airway inflammatory
response following exposure to inhaled antigen.
It is apparent that a degree of allergic airway eosinophilia
can be achieved via a lengthy protocol of chronic airway
exposure to antigen.
 
5,6
 
 However, simple immunization of mice
using two i.p. injections of antigen in alum adjuvant can
sensitize C57BL/6 mice such that a profound airway inflam-
matory response is induced by just a single exposure to inhaled
antigen.
 
7,8
 
 In the present study, we sought to determine whether
the route of allergen sensitization influenced the development
of antigen-induced airway inflammation. Surprisingly, immu-
nization of C57BL/6 mice via the s.c. route failed to sensitize
the airways towards inflammatory responses, despite the fact
that a comparable level of antigen-specific IgG1 and IgE was
induced by s.c. and i.p. immunization.
To investigate the role of T-cell activation and localization
in these observations, we used a model in which the allergic
airway inflammation was mediated by TCR transgenic CD4
 
+
 
T cells transferred into syngeneic B10.A mice. These studies
showed that immunization via the i.p. was an efficient means
of activating T-cell responses resulting in an increased
number of activated allergen-specific T cells present in the
circulation and lung of immunized mice, which correlated
directly with the ability of these mice to respond to inhaled
antigen. In contrast, s.c. immunization resulted in a small and
localized response that was not sufficient for the development
of airway responsiveness. This raises the possibility that all
individuals may harbour activated Th2 cells specific for
environmental allergens but that the atopic condition requires
(i) that these cells are already present at the site of allergen
contact and/or (ii) the maintenance of sufficiently large
numbers of allergen-specific cells within the circulation.
 
Materials and methods
 
Mice
 
The –I line of 5C.C7 TCR transgenic and B10.A mice were bred and
maintained at the Animal Facility of the Wellington School of
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Medicine (University of Otago, Wellington, New Zealand). The –I
line of the 5C.C7 transgenic mice was backcrossed to B10.A mice
and maintained by breeding transgenic males to B10.A females. The
TCR used to generate the 5C.C7 transgenic strain was derived from
the cytochrome 
 
c
 
 specific T-cell clone 5C.C7.
 
9,10
 
 These cells are
specific for pigeon cytochrome 
 
c
 
 peptide 81–104 (PCC) and I-E
 
k
 
, but
proliferate more vigorously when stimulated with peptide fragment
81–103 from the tobacco horn worm moth cytochrome 
 
c
 
 (MCC).
 
11
 
All animal experimental procedures used in this study were approved
by the Wellington School of Medicine Animal Ethics Committee, and
were carried out in accordance with the guidelines of the University
of Otago, New Zealand.
 
Reagents and mAbs
 
The synthetic MCC peptide KAERADLIAYLKQATK was obtained
from Chrion Mimotopes (Melbourne, Victoria, Australia), and is
formed from the two N-terminal residues of PCC together with the
C-terminal sequence of MCC. Because the N-terminal residues have
been shown not to be involved in MHC binding or TCR recognition,
 
12
 
this peptide is referred to as MCC for simplicity. Monoclonal anti-
CD4 (GK1.5) was grown from hybridoma culture supernatant and
conjugated to biotin. Anti-V
 
α
 
11-FITC, anti-V
 
β
 
3-phycoerythrin (PE),
anti-V
 
β
 
3-biotin, anti-CD44-PE, anti-CD62L-PE and strepdavidin-
Cy-chrome C were all obtained from Pharmingen (San Diego, CA,
USA) and used at a 1:100 dilution.
 
Antigen-induced airway inflammation
 
The model of ovalbumin (OVA)-induced airway inflammation has
been described previously.
 
7
 
 Briefly, it involves two immunizations of
C57BL/6 mice with 2 
 
µ
 
g OVA in 200 
 
µ
 
L of alum adjuvant via the
i.p. or s.c. (at the base of the neck) route at day zero and day 14,
followed 7 days later by an i.n. challenge with 100 
 
µ
 
g OVA in PBS.
In the model of MCC-induced airway inflammation, similar protocols
are followed as in the OVA model except that MCC is substituted for
OVA in the immunization regime and B10.A mice are used as hosts
for the adoptively transferred MCC specific transgenic T cells.
Specifically, cell suspensions were made from lymph nodes of 5C.C7
mice and the percentage of total lymphocytes that expressed the
transgenic V
 
α
 
11
 
+
 
V
 
β
 
3
 
+
 
 TCR was determined by FACS analysis. Cell
concentrations were adjusted so that 3–5 
 
×
 
 10
 
6
 
 T cells expressing the
transgenic TCR would be present in a total volume of 500 
 
µ
 
L in
incomplete modified Dulbecco’s medium (IMDM), and this volume
was injected into the tail vein of sex matched B10.A mice. Two days
later, recipient mice were primed i.p. or s.c. with 250 
 
µ
 
g MCC in
200 
 
µ
 
L alum adjuvant on day two and day 22. Six days after the
second i.p. or s.c. immunization (day 28) mice were anaesthetized by
injection of a mixture of Ketamine and Xylazine (Phoenix, Auckland,
New Zealand), and 100 
 
µ
 
g MCC in a 50 
 
µ
 
L volume of PBS adminis-
tered by i.n. inoculation. For both the OVA and MCC allergen
models, airway inflammation was determined at day four following
i.n. challenge by performing broncho-alveolar lavage (BAL) and
differential cell counts were performed as previously described.
 
7
 
Histology of the lungs
 
Lungs of OVA immunized mice were collected at day 10 after the
second i.p. or s.c. immunization. Lungs were immediately placed into
2–3 mL of 10% phosphate-buffered formalin. Fixed tissues were then
embedded in paraffin and 2–3 
 
µ
 
m sections were cut and mounted
onto glass slides. Sections were stained with haematoxylin–eosin
(HE) and examined by light microscopy.
 
Analysis of serum antibody levels
 
OVA-specific IgG or total serum IgE levels were determined by
ELISA. Dilutions of test sera were made on 96-well plates (Nalge
Nunc International, Rochester, NY, USA) coated overnight at 4
 
°
 
C
with 100 
 
µ
 
g/mL OVA (Sigma, St Louis, MO, USA) or with anti-IgE
capture antibody (clone 4B3-39). Plates were blocked with PBS plus
5% BSA (Sigma) then incubated with serial dilutions of serum
samples. Antibody binding was detected with peroxidase-labelled
goat antimouse IgG1 (Sigma) or biotinylated anti-IgE detecting
antibody (clone 3-11). Binding of anti-IgE antibody was visualized
by further incubation with peroxidase-labelled strepdavidin. All
reactions were developed with 1 mmol/L ABTS (Sigma) in citrate
phosphate buffer (pH 9.2) and 0.03% hydrogen peroxide. Reactions
were stopped at the appropriate time with 2 mmol/L sodium azide
and the development of the coloured product was quantified by
measuring absorbance at 414 nm using an Anthos Hill (Anthos, Wals,
Austria) plate reader. OVA-specific IgG1 titres are expressed in
U/mL (reciprocal of 50% antibody titre), whilst total serum IgE is
expressed in ng/mL.
 
Isolation of mononuclear cells from lymphoid and 
peripheral tissues
 
Peripheral blood lymphocytes were isolated by collecting 100 
 
µ
 
L of
tail blood into 1 mL Alsevers solution (20.5 g dextrose, 4.2 g NaCl,
8 g sodium citrate, 1 L H
 
2
 
O). For the isolation of lymphocytes from
the lung, lymph nodes or spleen, mice were injected i.p. with 150 µL
heparin (1 IU/mL; Leo Pharmaceutical Products, Ballerup, Denmark),
anaesthetized, then perfused via the right heart ventricle with approxi-
mately 5 mL PBS. Mice were then killed and lung tissue was
incubated for 30 min in complete IMDM containing 2.4 
 
µ
 
g/mL
collagenase type II (Gibco-BRL, Life Technologies, Gaithersburg,
MD, USA) and 0.1% DNase1 (Sigma). Complete IMDM consisted of
IMDM (Sigma) plus 5% FCS (Gibco BRL), 2 mmol/L glutamine
(Sigma), 1% penicillin-streptomycin (Sigma) and 5 
 
×
 
 10
 
–5
 
 mol/L 2-ME
(Sigma). Remaining tissue was dispersed by passage through an 18
gauge needle, and mononuclear cells were purified by gradient
centrifugation over Lympholyte-M (Cedarland Laboratories, Hornby,
Ontario, Canada) or 70% Percoll (Pharmacia Biotech, Uppsala,
Sweden) as per manufacturer’s instructions. Lymph nodes and
spleens were collected into IMDM then made into cell suspensions
by squeezing through two layers of gauze. Red blood cells from
blood or spleen were lysed by incubation in 3 mL 0.14 mol/L NH
 
4
 
Cl,
17 mmol/L Tris-HCl for 5 min or 10–20 min, respectively, at 37
 
°
 
C.
 
FACS analysis
 
FACS analysis of lymphocytes was carried out in 96-well round
bottom plates using 10
 
5
 
–10
 
–6
 
 cells per well, incubated with the
indicated mAb diluted in 100 
 
µ
 
L FACS buffer (PBS with 2% FCS
and 0.01% sodium azide) for 10–15 min on ice. All samples were
subjected to prior incubation with 2.4G2 (10 
 
µ
 
g/mL) to inhibit
 
Fc
 
γ
 
RII-mediated uptake of mAbs. Flow cytometric analysis was
performed on a FACSort (Becton Dickinson, Franklin Lakes, NJ,
USA) using the CellQuest software. For all samples, between 50 000
and 100 000 live cells were collected for analysis.
 
Dendritic and T-cell co-culture
 
Mononuclear cells were isolated from the lung as described above.
Peritoneal cells were collected by flushing the peritoneal cavity with
10 mL PBS and resuspending the pellet in complete IMDM. For all
samples, 0.6 mL of 0.1 mol/L EDTA (pH 7.2) was added for every
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7 mL of cell suspension, and samples were passed through a stainless
steel sieve, layered over cold FCS containing 0.1 mol/L EDTA (FCS-
EDTA) and then centrifuged. Pellets were resuspended in 5 mL cold
Nycodenz (Progen, Heidelberg, Germany) and layered on top of a
further 5 mL of cold Nycodenz. A final layer of 1–2 mL FCS-EDTA
was added to the top of the sample and samples were spun for
10–15 min at 400 
 
g
 
. All cells except the pellet were collected and
stained with anti-CD11c (N418) mAb-biotin for 30 min on ice in PBS
containing 2 mmol/L EDTA and 2% BSA. CD11c
 
+
 
 cells were puri-
fied using Strepdavidin MicroBeads (MACs Reagents; Miltenyi
Biotec, Bergisch Gladbach, Germany) according to the manu-
facturer’s instructions. Enriched DC were cultured at the indicated
concentrations in cIMDM in a 96-well plate (Nunc) with lymph node
cells (2 
 
×
 
 10
 
5
 
/well) from 5C.C7 TCR transgenic mice. Assays were
incubated for 72 h at 37
 
°
 
C with [
 
3
 
H] thymidine added (1 
 
µ
 
Ci/well)
for the last 12 h. Total [
 
3
 
H] thymidine incorporation was measured as
an indicator of cell proliferation.
 
Results
 
I.p. but not s.c. immunization results in sensitization of the 
airways
 
C57BL/6 mice were immunized twice with identical doses of
OVA antigen in alum adjuvant via the s.c. or i.p. route on
days zero and 14. Ten days later, mice received an i.n.
challenge with OVA, and the resulting airway eosinophilia
and antibody response was analysed. Immunization via the
i.p. route sensitized animals such that a single i.n. exposure
to soluble OVA induced a profound airway eosinophilia
(Fig. 1a). Surprisingly, s.c. immunization with an identical
quantity of OVA in the same volume of alum adjuvant failed
to result in the mice becoming responsive to inhaled OVA
(Fig. 1a). Even when mice received three s.c. OVA/alum
immunizations rather than the usual two, no sensitization of
the lung was observed (Fig. 1a). However, both i.p. and s.c.
immunized mice produced OVA-specific IgG1 (Fig. 1b) and
had increased levels of total IgE (Fig. 1c), indicating that
comparable B-cell responses were induced within the lym-
phoid tissues of both groups of mice.
To analyse the contribution of allergen-specific T cells to
the airway inflammatory response, we used a model of airway
eosinophilia whereby the inflammatory response is driven by
TCR transgenic T cells.
 
13
 
 In this model, 3–5 
 
×
 
 10
 
6
 
 5C.C7
T cells expressing the transgenic V
 
α
 
11
 
+
 
V
 
β
 
3
 
+
 
 TCR were
injected i.v. into normal syngeneic B10.A mice, and 2 days
later, recipient mice were immunized with 250 
 
µ
 
g MCC
peptide in alum adjuvant (days two and 22). On day 28,
recipient mice received an i.n. challenge with 100 
 
µ
 
g MCC in
PBS, and cellular infiltration into the airways was determined
by BAL 4 days later. As reported for OVA immunization and
airway challenge, mice immunized via the i.p. but not the s.c.
route developed an acute airway inflammatory response
(characterized by eosinophil and lymphocyte accumulation)
following i.n. challenge (Fig. 3a). Importantly, no airway
eosinophilia was observed in B10.A mice that were immu-
nized i.p. and challenged i.n. with MCC, but which had not
received 5C.C7 T cells, indicating that the response was
driven solely by the TCR transgenic T cells with no contribu-
tion by endogenous T cells (Fig. 3a). To investigate the
T-cell response, we analysed the proportion of V
 
α
 
11V
 
β
 
3
 
+
 
T cells present in the lungs following i.n. challenge. These
cells represented 24% of total CD4
 
+
 
 T cells in mice immu-
nized via the i.p. route and receiving an i.n. challenge,
whereas the proportion of V
 
α
 
11V
 
β
 
3
 
+
 
 T cells in mice immu-
nized via the s.c. route remained at the level seen in control,
non-immunized mice (Fig. 3b).
These data indicate that only the i.p. route of immuniza-
tion can sensitize mice towards the development of acute
airway inflammatory responses following allergen inhalation,
and that this response occurs in parallel with the recruitment
of allergen-specific T cells to the lung.
 
Figure 1
 
I.p. and s.
 
c. 
 
immunization with ovalbumin (OVA)/
alum had different consequences for lung inflammatory responses
following airway exposure to OVA. Mice were immunized twice
(days 0 and 14) or three times (days 0, 14 and 28) i.p. or s.c. with
2 
 
µ
 
g OVA in 200 
 
µ
 
L alum adjuvant. Seven days later, mice were
anaesthetized and given 100 
 
µ
 
g OVA in 50 
 
µ
 
L of PBS by i.n.
inoculation. (a)
 
 
 
At day three after the i.n. challenge, mice were
killed and a broncho-alveolar lavage (BAL) was performed using
1 mL PBS flushed three times into the lung. Differential cell
counts on Diff Quik (Dade-Behring, Deerfield, IL, USA stained
cytospins were performed to determine the number of infiltrating
eosinophils. Blood was collected (b)
 
 
 
at the time the mice were
killed following the i.n. challenge or (c) 6 days after the second
immunization, and OVA-specific serum IgG1 or total IgE was
measured, respectively. Data represent pooled values for four to
five mice and are representative of three separate experiments.
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I.p. but not s.c. immunization results in the accumulation of 
activated allergen-specific T cells in the lung and 
circulation before i.n. challenge
 
We observed that C57BL/6 mice immunized with OVA via the
i.p. route had a mononuclear infiltrate surrounding the airways
even before being subjected to i.n. challenge (Fig. 2). In con-
trast, the airways of mice immunized via the s.c. route were
normal, without signs of lymphoid infiltrate (Fig. 2). It was
plausible that this infiltrate might contain allergen-specific
T cells that would respond to inhaled allergen and contribute to
the allergic inflammatory response. We therefore investigated
the effect of i.p. or s.c. immunization with MCC/alum on the
accumulation of T cells expressing V
 
α
 
11
 
+
 
V
 
β
 
3
 
+
 
 TCR in various
tissues before the administration of i.n. MCC.
As expected, i.p. immunization with MCC/alum resulted
in a marked accumulation of V
 
α
 
11
 
+
 
V
 
β
 
3
 
+
 
 T cells at the site of
peptide deposit (peritoneum) and in the draining lymphoid
tissues (spleen and mediastinal lymph node) (Table 1). More
interestingly, i.p. immunization appeared to increase the pro-
portion of V
 
α
 
11
 
+
 
V
 
β
 
3
 
+
 
 T cells found within all tissues investi-
gated, including non-draining lymph nodes and lung (Table 1).
In contrast, s.c. immunization consistently increased the per-
centage of CD4
 
+
 
 T cells expressing the V
 
α
 
11
 
+
 
V
 
β
 
3
 
+
 
 TCR in
the draining axillary and brachial lymph nodes, but did not
result in the significant accumulation of V
 
α
 
11
 
+
 
V
 
β
 
3
 
+
 
 T cells
within any other tissue investigated (Table 1). Similar trends
to those shown in Table 1 (day three after the second immuni-
zation) were also seen at a later time point (day seven),
indicating that these observations were not simply a result of
differences in the kinetics of T-cell expansion or circulation
following i.p. versus s.c. immunization. The total numbers of
V
 
α
 
11
 
+
 
V
 
β
 
3
 
+
 
 CD4
 
+
 
 T cells detected within all investigated
tissues of mice immunized i.p. with MCC/alum increased
approximately 20-fold over those levels found in mice
immunized with alum alone (5.5 
 
×
 
 10
 
6
 
 
 
vs
 
 2.5 
 
×
 
 10
 
5
 
). In com-
parison, the numbers of antigen-specific T cells in mice
immunized s.c. increased only 1.2-fold over background
(4.2 
 
×
 
 10
 
5
 
 vs 3.3 × 105).
We have previously shown that the proportion of Vα11+Vβ3+
T cells in the blood increases following the second i.p.
immunization with MCC, and that these cells are quickly
depleted following i.n. challenge,13 presumably reflecting
their migration into the lung. We therefore monitored the
proportion of Vα11+Vβ3+ T cells in the blood of i.p. and s.c.
immunized mice before and following i.n. challenge. As
Figure 2 (a) I.p. and (b) s.c. immunization with ovalbumin
(OVA)/alum had different consequences for lung inflammatory
responses following airway exposure to OVA. Mice were
immunized twice (days 0 and 14) i.p. or s.c. with OVA/alum, then
10 days after the last immunization, lungs were fixed, embedded
in paraffin, and sections were stained with haematoxylin–eosin
(HE) as detailed in the Materials and methods. Histological
sections are shown at 40× magnification. 
(a)
(b)
Table 1 Proportion of CD4+ T cells expressing the Vα11+Vβ3+ TCR present in various tissues following i.p. or s.c. immunization with MCC/alum
Tissue S.c. immunization I.p. immunization 
Alum MCC + alum Alum MCC + alum
S.c. draining tissues Skin 1.2 5.5† 0 3.1†
Axillary lymph node 1.6 2.7† 1.8 2.8†
I.p. draining tissues Peritoneum 0.5 1.4 0.2 21.7†
Blood 2 0.9 2.3 3.9
Spleen 1.9 1.3 1.5 7.3†
Lung 1.4 1.2 1.3 9.5†
Mediastinal lymph node 0.7 1.7 ND 6.5
†Values significantly greater than those obtained following alum immunization alone using a Student’s t-test (P ≤ 0.05).
ND, not done.
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expected, the proportion of Vα11+Vβ3+ T cells was increased
in the blood of i.p. immunized mice, but these were rapidly
lost following i.n. challenge (Fig. 4). Interestingly, the pro-
portion of Vα11+Vβ3+ T cells present in the blood of s.c.
immunized mice was barely detectable, being no higher than
that found in non-immunized mice, and the level of these cells
did not alter following i.n. challenge (Fig. 4).
To ensure that s.c. immunization did actually result in
T-cell activation, we analysed the expression of CD62L and
CD44 by Vα11+Vβ3+ CD4+ T cells in the spleen of i.p.
immunized mice, or the axillary lymph node of s.c. immu-
nized mice, because these represent the major draining
lymphoid organs following challenge via either route. As
expected, Vα11+Vβ3+ CD4+ T cells from naive 5C.C7 mice
were CD62LhiCD44med (Fig. 5; dashed line), consistent with a
naive phenotype. In contrast, Vα11+Vβ3+ CD4+ T cells from
the spleens of mice immunized i.p., or the axillary lymph
node of mice immunized s.c., were CD62Lmed–loCD44hi
(Fig. 5; solid line), consistent with an activated phenotype.
Note though that Vα11+Vβ3+ CD4+ T cells from s.c. immu-
nized mice did show a less dramatic downregulation of
CD62L compared to that seen following i.p. immunization.
These data indicate that both i.p. and s.c. immunization
with MCC/alum can induce the activation of Vα11+Vβ3+
CD4+ T cells within draining lymphoid tissues, but that only
i.p. immunization results in a greater number of activated
T cells in the circulation, non-draining lymph nodes and lung.
I.p. immunization does not cause antigen deposition in the 
lung
It was not clear whether the accumulation of allergen-specific
T cells within the lung of i.p. immunized mice before i.n.
challenge reflected non-specific trafficking of activated peptide-
specific T cells from the blood through peripheral tissues, or a
process of selective recruitment. We reasoned that the major
factor likely to drive the specific recruitment of T cells to the
lung would be the presence of antigen at this site. We therefore
conducted an experiment designed to determine whether i.p.
immunization can result in the deposition of antigen within
the lung. For this purpose, we immunized mice i.p. with 1 mg
MCC peptide, isolated CD11c+ dendritic cells (DC) from the
peritoneal cavity and the lung 24 h later, then co-cultured the
DC with naive 5C.C7 TCR transgenic T cells. A similar
degree of enrichment was obtained from both sites (between
70 and 90% CD11c+ cells); however, these were likely to
represent different subpopulations of DC. MCC peptide pres-
entation by CD11c+ DC isolated from the peritoneal cavity or
lung following i.p. immunization was then determined by
their ability to stimulate the proliferation of naive Vα11+Vβ3+
T cells. As expected, CD11c+ DC isolated from the peritoneal
cavity were able to induce Vα11+Vβ3+ T-cell proliferation
(Fig. 6a). In contrast, CD11c+ DC isolated from the lungs of
i.p. immunized mice did not induce Vα11+Vβ3+ T-cell prolif-
eration, even when very high numbers of DC were used (Fig. 6b).
Figure 3 I.p. immunization, but
not s.c. immunization, with MCC/
alum induced airway inflamma-
tion following MCC i.n. chal-
lenge. Vα11+Vβ3+ CD4+ T cells
(3–5 × 106) were injected i.v. into
B10.A mice on day zero. At day
two and 22 recipient mice were
immunized either s.c. or i.p. with
250 µg MCC in 200 µL alum adju-
vant. On day 28, mice were anaes-
thetized and given 100 µg MCC in
50 µL of PBS by i.n. inoculation.
(a) Four days later, mice were
killed and broncho-alveolar lavage
(BAL) and differential cell counts
were performed as detailed in
Figure 1. Data represent mean ± SD
of five to six mice per group and
are representative of two separate
experiments. (b) Lung cells from
the same mice were stained with
anti-CD4-biotin, SA-Cy-chrome C,
anti-Vα11-FITC and anti-Vβ3-PE,
then analysed by FACS. Dot plots
show cells from one mouse, are
gated for CD4 expression and are
representative of seven to ten
animals per group from two sepa-
rate experiments. Numbers indi-
cate the percentage of gated CD4+
T cells expressing Vα11 and Vβ3.
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These data indicate that MCC is not detectable on CD11c+
DC present in the lungs of mice following i.p. immunization,
and that the presence of peptide-specific T cells at this
location is therefore likely to represent non-specific traffick-
ing of activated cells into peripheral tissues.
Discussion
Our data indicate that immunization via the i.p. or s.c. route
has very different consequences for lung inflammatory
responses following airway exposure to antigen. Both i.p. and
s.c. immunization were sufficient to induce CD4+ T-cell
activation and T-cell-dependent B-cell antibody production.
However, only immunization via the i.p. route could sensitize
C57BL/6 mice to subsequent lung inflammatory responses.
These findings can in part be explained by the observation
that i.p. immunization with antigen or peptide in alum led to
the accumulation of specific T cells into the lung before i.n.
challenge. In contrast, s.c. immunization resulted in the
activation of antigen-specific T cells in the draining axillary
lymph nodes, but did not promote accumulation of these cells
in lung tissue or predispose the host towards the development
of an airway inflammatory response. This was true even when
an increased amount of antigen was used in the s.c. immuni-
zation procedure. T-cell recruitment to the lung of i.p. immu-
nized mice does not appear to be driven by antigen deposits at
this site, and may instead reflect the increased number of
activated T cells present in the circulation of these mice.
However, the presence of activated T cells in the lung of
i.p. immunized mice before i.n. challenge is unlikely to be the
Figure 4 I.p. immunization, but not s.c. immunization, with
MCC/alum induced accumulation of Vα11+Vβ3+ CD4+ T cells in
the blood before i.n. challenge. B10.A mice were injected with
Vα11+Vβ3+ CD4+ T cells then subjected to MCC immunization
and i.n. challenge as detailed in Figure 3. Blood was collected from
the tail into Alsever’s solution at the indicated time points before
and after the i.n. challenge and lymphocytes were stained with anti-
CD4-biotin, SA-Cy-chrome C, anti-Vα11-FITC and anti-Vβ3-PE
then analysed by FACS. Data show mean ± SD of five to six mice
per group and are representative of three separate experiments.
, s.c. immunization; , i.p. immunization; , non-immunized.
Figure 5 Both i.p. and s.c. immunization with MCC/alum induced the expression of activation markers on V α11+Vβ3+ CD4+ T cells.
B10.A mice were injected with Vα11+Vβ3+ CD4+ T cells then subjected to MCC immunization as detailed in Figure 3. Three days
following the second immunization, mice were killed and cell suspensions were made from spleen (i.p. immunized mice) or axillary lymph
nodes (s.c. immunized mice). Cell suspensions were stained with anti-Vβ3-biotin, SA-Cy-chrome C, anti-Vα11-FITC and anti-CD44-PE
or anti-CD62L-PE. Dot plots show cells gated for Vα11 and Vβ3 expression. Dashed lines indicate naive Vα11+ Vβ3+ T cells from blood
of 5C.C7 mice; solid lines indicate Vα11+ Vβ3+ T cells from MCC/alum immunized mice. Dot plots show cells from one mouse and are
representative of three to four individual animals.
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only explanation for the observed increase in airway inflam-
matory responses. I.p. immunization also resulted in the
production of a larger pool of activated Vα11+Vβ3+ CD4+
T cells in the blood compared to s.c. immunization. These
cells are likely to represent the pool of antigen-specific T cells
available for recruitment into the lung immediately following
i.n. challenge, resulting in the generation of an increased
airway inflammatory response.
Another possible explanation for the differences seen in
lung inflammatory responses in i.p. and s.c. immunized mice
is that functionally different T cells are generated in these two
groups. A number of recent studies have indicated that Th1
and Th2 cells express distinct sets of adhesion molecules14
and chemokine receptors,15–17 resulting in differences in the
recruitment patterns of these cells into inflamed peripheral
tissues. In the present study, the levels of OVA-specific IgG1
total IgE were similar in mice immunized with OVA/alum via
the i.p. or s.c. route, indicating that both routes of immuniza-
tion can induce the development of a Th2 response. Thus,
these cells probably express a similar set of surface receptors,
although we have not formally tested this.
Of special note, large differences were found in the total
number of activated Vα11+Vβ3+ CD4+ T cells generated
following i.p. or s.c. immunization with MCC. Therefore,
the similarities in IgG1 and IgE levels seen in i.p. or s.c.
immunized mice may reflect that B cells, not T cells, are
limiting in the generation of an antibody response. This view
is supported by a previous finding in our laboratory that anti-
CTLA-4 mAb treatment of mice infected with Nippostrong-
lyus brasiliensis significantly increases the pool of IL-4- and
IL-5-producing T cells in the draining lymph nodes,18 but
does not alter the antibody response (K. McCoy and G. Le
Gros, unpubl. obs., 1998).
Many investigators have reported that allergen sensitiza-
tion of BALB/c mice via the s.c. route is sufficient for the
induction of allergic airway inflammation.19,20 BALB/c mice
are well accepted to generate a more robust Th2 response, and
to show increased allergic airway inflammatory responses
compared to C57BL/6 mice.19 Thus we feel that the differ-
ences between these reports and our findings are likely to
reflect the genetic background of the strains used, perhaps
resulting from different frequencies of atopy inducing Th2
cells generated in these various strains. Alternatively, the
precise site of s.c. immunization, or the number and fre-
quency of i.n. challenges administered, may play a role.
In summary, in our model, i.p. immunization with antigen
or peptide in alum leads to the generation of a larger number
of lung resident and circulating activated CD4+ T cells in the
peripheral blood compared to s.c. immunization. Following
i.n. challenge, the cells resident within the lung of i.p.
immunized mice could respond immediately, and the ensuing
inflammatory response would result in further accumulation
of specific T cells from the blood and hence accentuate the
response. Although s.c. immunized mice contained previ-
ously activated allergen-specific T cells, these cells were not
available in high enough numbers, or within the appropriate
location, required for the induction of an acute airway inflam-
matory response. These findings indicate that the mere pres-
ence of responsive Th2 cells may not be sufficient for atopic
asthma. Instead, the development of atopy may be largely
determined by the frequency and tissue localization of
allergen-specific Th2 cells.
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